Editorial
Research, a call for action
Main Article Content
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
References
1. Corneli A, Pierre C, Hinkley T, Lin L, Fordyce CB, Hamre G, et al. One and done: Reasons principal investigators conduct only one FDA-regulated drug trial. Contemp Clin Trials Commun. 2017;6:31-38. doi: 10.1016/j.conctc.2017.02.009. Fordyce CB, Malone K, Forrest A, Hinkley T, Corneli A, Topping J, et al. Improving and sustaining the site investigator community: Recommendations from the Clinical Trials Transformation Initiative. Contemp Clin Trials Commun. 2019;16:100462. doi: 10.1016/j.conctc.2019.100462.